From: Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
Upregulated miRNAs | Downregulated miRNAs | ||||
---|---|---|---|---|---|
miRNA treated vs untreated | Fold change | p value | miRNA treated vs untreated | Fold change | p value |
hsa-miR-16 | 1.99 | 0.00001 | hsa-miR-125b (#^) | 0.17 | 0.00001 |
hsa-miR-15a | 2.65 | 0.00001 | hsa-miR-760 (#^) | 0.08 | 0.00005 |
hsa-miR-124 | 6.42 | 0.00012 | hsa-miR-135a (#^) | 0.18 | 0.00058 |
hsa-miR-26b | 1.91 | 0.00044 | hsa-miR-134 (#^) | 0.1 | 0.00183 |
hsa-miR-7 | 3.8 | 0.00085 | hsa-miR-138 (#^) | 0.18 | 0.00515 |
hsa-miR-15b | 1.79 | 0.00206 | hsa-miR-423-3p (#) | 0.4 | 0.00734 |
hsa-miR-451 | 1.85 | 0.00233 | hsa-miR-100 (#) | 0.31 | 0.00818 |
hsa-miR-454 | 2.09 | 0.00458 | hsa-miR-125a | 0.24 | 0.00925 |
hsa-miR-17 | 1.66 | 0.00735 | hsa-miR-135b(#^) | 0.18 | 0.01455 |
hsa-miR-144 | 2.13 | 0.01293 | hsa-miR-203 (#) | 0.2 | 0.01629 |
hsa-miR-1180 | 3.53 | 0.01837 | hsa-miR-660 (#) | 0.31 | 0.04582 |
hsa-miR-106a | 1.71 | 0.01897 | hsa-miR-30d | 0.34 | 0.000002 |
hsa-miR-184 | 3.41 | 0.03243 | hsa-miR-200c | 0.09 | 0.00003 |
hsa-miR-374b | 1.62 | 0.03371 | hsa-miR-30a | 0.18 | 0.00003 |
hsa-miR-99a | 0.1 | 0.00009 | |||
hsa-miR-29a | 0.25 | 0.00034 | |||
hsa-miR-200b | 0.1 | 0.00043 | |||
hsa-miR-24 | 0.47 | 0.00076 | |||
hsa-miR-30e | 0.33 | 0.001 | |||
hsa-miR-27b | 0.38 | 0.00199 | |||
hsa-let-7c | 0.44 | 0.00711 | |||
hsa-miR-375 | 0.14 | 0.00836 | |||
hsa-miR-152 | 0.23 | 0.01717 | |||
hsa-miR-148b | 0.43 | 0.01862 | |||
hsa-miR-361-5p | 0.23 | 0.01937 | |||
hsa-miR-221 | 0.46 | 0.02188 | |||
hsa-miR-200a | 0.21 | 0.02416 | |||
hsa-miR-328 | 0.4 | 0.02717 | |||
hsa-miR-92a | 0.71 | 0.02719 | |||
hsa-miR-27a | 0.48 | 0.0307 | |||
hsa-miR-181a | 0.49 | 0.04338 | |||
hsa-miR-143 | 0.38 | 0.04993 |